- ISIN
- CA68620P1018
- CUSIP
- 68620P101
- Sector
- Healthcare
- IPO Date
- Aug 27, 2014
Highlights
- Market Cap
- $126.31M
- Enterprise Value
- $94.62M
- EPS (TTM)
- -CA$0.19
- Total Revenue (TTM)
- CA$274.29M
- Gross Profit (TTM)
- CA$72.27M
- EBITDA (TTM)
- -CA$17.68M
- Year Range
- $0.95 - $2.24
- ROA (TTM)
- -4.83%
- ROE (TTM)
- -6.77%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
OGI Performance Chart
OrganiGram Holdings Inc. (OGI) is down 42.9% since the beginning of the year. At $1 per share, OGI is trading 57.1% below its 52-week high of $2. Investors who bought $1,000 worth of OGI shares 5 years ago would now be looking at an investment worth $81.
Loading charts...
Returns By Period
OrganiGram Holdings Inc. (OGI) has returned -42.86% so far this year and -25.58% over the past 12 months. Over the last ten years, OGI has returned -11.33% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
OrganiGram Holdings Inc.
- 1D
- -0.49%
- 1M
- -14.29%
- YTD
- -42.86%
- 6M
- -50.00%
- 1Y
- -25.58%
- 3Y*
- -15.66%
- 5Y*
- -39.54%
- 10Y*
- -11.33%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
OGI Monthly Returns History
Based on dividend-adjusted daily data since Aug 27, 2014, OGI's average daily return is +0.06%, while the average monthly return is +0.70%. At this rate, an investment would double in approximately 8.3 years.
Historically, 43% of months were positive and 57% were negative. The best month was Oct 2015 with a return of +167.8%, while the worst month was Dec 2014 at -42.7%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 8 months.
On a daily basis, OGI closed higher 44% of trading days. The best single day was Jan 15, 2020 with a return of +45.4%, while the worst single day was Feb 11, 2021 at -38.8%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -10.71% | -4.67% | -6.29% | 5.22% | -19.15% | -15.79% | -42.86% | ||||||
| 2025 | -6.83% | -23.33% | -12.17% | 14.85% | 16.38% | -0.00% | -0.74% | 29.10% | 17.34% | -20.20% | 1.23% | 2.44% | 4.35% |
| 2024 | 26.72% | 24.70% | 3.86% | -1.40% | -19.34% | -9.94% | 9.09% | 10.12% | -2.16% | -5.52% | -11.70% | 6.62% | 22.90% |
| 2023 | 13.63% | -13.20% | -18.88% | -21.87% | -25.80% | 5.12% | -2.56% | 7.89% | -19.51% | -20.45% | 21.90% | 2.34% | -59.06% |
| 2022 | -14.86% | -0.00% | 11.41% | -15.06% | -18.44% | -20.25% | 16.67% | -0.00% | -18.54% | 17.03% | 0.98% | -22.33% | -54.29% |
| 2021 | 37.59% | 65.57% | 14.52% | -23.49% | 20.90% | -10.90% | -8.39% | 1.91% | -13.86% | -3.91% | -7.69% | -14.22% | 31.58% |
Benchmark Metrics
OrganiGram Holdings Inc. has an annualized alpha of -1.11%, beta of 1.18, and R2 of 0.07 versus S&P 500 Index. Calculated based on daily prices since August 27, 2014.
- This stock participated in 185.38% of S&P 500 Index downside but only 67.18% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.07 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -1.11%
- Beta
- 1.18
- R²
- 0.07
- Upside Capture
- 67.18%
- Downside Capture
- 185.38%
Return for Risk
Risk / Return Rank
OGI ranks 24 for risk / return — below 24% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for OrganiGram Holdings Inc. (OGI) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| OGI | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.45 | ||
| Sortino ratioReturn per unit of downside risk | -3.04 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 1.37 | -0.40 |
| Calmar ratioReturn relative to maximum drawdown | -0.47 | 2.78 | -3.26 |
| Martin ratioReturn relative to average drawdown | -0.97 | 12.44 | -13.41 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the OrganiGram Holdings Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the OrganiGram Holdings Inc. was 97.37%, occurring on Apr 8, 2025. The portfolio has not yet recovered.
The current OrganiGram Holdings Inc. drawdown is 97.13%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 selloff2025 | -97.37%Apr 2025 | 5y 10mo | — | 7y 1moMay 2019 - now |
2015 bear market2015 | -91.90%Oct 2015 | 1y 1mo | 1y 13d | 2y 1moAug 2014 - Oct 2016 |
Rate-hike selloffLate 2018 | -50.48%Dec 2018 | 2mo 12d | 2mo 1d | 4mo 13dOct 2018 - Feb 2019 |
2017 bear market2017 | -48.81%Mar 2017 | 3mo 23d | 8mo 24d | 1y 12dNov 2016 - Nov 2017 |
2018 bear market2018 | -37.76%Apr 2018 | 2mo 14d | 1mo 28d | 4mo 12dJan 2018 - Jun 2018 |
Drawdown Indicators
| OGI | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.37% | -56.78% | -40.59% |
Max Drawdown (1Y)Largest decline over 1 year | -54.50% | -9.10% | -45.40% |
Max Drawdown (3Y)Largest decline over 3 years | -67.65% | -18.90% | -48.75% |
Max Drawdown (5Y)Largest decline over 5 years | -92.83% | -25.43% | -67.40% |
Max Drawdown (10Y)Largest decline over 10 years | -97.37% | -33.92% | -63.45% |
Current DrawdownCurrent decline from peak | -97.13% | -1.80% | -95.33% |
Average DrawdownAverage peak-to-trough decline | -67.04% | -10.71% | -56.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 26.42% | 2.03% | +24.39% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of OrganiGram Holdings Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how OrganiGram Holdings Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for OGI relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, OGI has a P/S ratio of 0.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for OGI in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, OGI has a P/B value of 0.5. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with OGI
Add OrganiGram Holdings Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with OGI